Childhood Cancer in the Primary Care Setting

Similar documents
Cancer in Children. What is cancer?

Leukemias and Lymphomas: A primer

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014

Table 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for

Oncology. Objectives. Cancer Nomenclature. Cancer is a disease of the cell Cancer develops when certain cells begin to grow out of control

Malignant Lymphomas and Plasma Cell Myeloma

New Hampshire Childhood Cancer

95% of childhood kidney cancer cases are Wilms tumours. Childhood kidney cancer is extremely rare, with only 90 cases a year in

Acute Myeloid Leukemia

Bone Marrow or Blood Stem Cell Transplants in Children With Severe Forms of Autoimmune Disorders or Certain Types of Cancer

Pediatric Oncology for Otolaryngologists

Symptoms of Hodgkin lymphoma

General Rules SEER Summary Stage Objectives. What is Staging? 5/8/2014

National Cancer Institute Research on Childhood Cancers. In the United States in 2005, approximately 9,510 children under age 15 will be

ACUTE MYELOID LEUKEMIA (AML),

Things You Don t Want to Miss in Multiple Myeloma

Introduction. About 10,500 new cases of acute myelogenous leukemia are diagnosed each

Metastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy

The Lewin Group undertook the following steps to identify the guidelines relevant to the 11 targeted procedures:

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Pre- Transformed Ig Surface Surface Secreted Myeloma Major malignant counterpart

Kidney Cancer OVERVIEW

Test Request Tip Sheet

Management of spinal cord compression

A Career in Pediatric Hematology-Oncology? Think About It...

A Rare Image. Dean M. Cestari, MD Fred Jakobiec, MD Fred Hochberg, MD Joseph F. Rizzo III, MD Rebecca C. Stacy, MD PhD

Headache: Differential diagnosis and Evaluation. Raymond Rios PGY-1 Pediatrics

Thymus Cancer. This reference summary will help you better understand what thymus cancer is and what treatment options are available.

A Framework of Competences for the Level 3 Training Special Study Module in Paediatric Oncology

NORD Guides for Physicians #1. Physician s Guide to. Tyrosinemia. Type 1

Leukaemia and lymphoma what s the difference?

LEARNING OUTCOMES. Identify children at risk of developing TB disease. Correctly manage and refer children suspected of TB. Manage child contacts

PATIENT HEALTH QUESTIONNAIRE Radiation Oncology (Patient Label)

NICE guideline Published: 23 June 2015 nice.org.uk/guidance/ng12

Cervical lymphadenopathy

Aggressive lymphomas. Michael Crump Princess Margaret Hospital

Enhancing the Child s Voice in Clinical Care and Research

Acute myeloid leukaemia (AML) in children

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.

Brain Cancer. This reference summary will help you understand how brain tumors are diagnosed and what options are available to treat them.

Something Old, Something New.

Multiple Myeloma. This reference summary will help you understand multiple myeloma and its treatment options.

Canine Lymphoma Frequently Asked Questions by Pet Owners

Primary -Benign - Malignant Secondary

Special Section: Cancer in Children & Adolescents

Guide to Critical Illness Definitions For guidance purposes only

Interesting Case Series. Periorbital Richter Syndrome

MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST?

Neoplasms of the LUNG and PLEURA

NEOPLASMS OF KIDNEY (RENAL CELL CARCINOMA) And RENAL PELVIS (TRANSITIONAL CELL CARCINOMA)

387

CLL. Handheld record. Stockport NHS foundation trust

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide

Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology

An overview of CLL care and treatment. Dr Dean Smith Haematology Consultant City Hospital Nottingham

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? Telephone

Diagnosis and Treatment of Common Oral Lesions Causing Pain

4/15/2013. bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o. anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma

Waldenström Macroglobulinemia: The Burning Questions. IWMF Ed Forum May Morie Gertz MD, MACP

LYMPHOMA IN DOGS. Diagnosis/Initial evaluation. Treatment and Prognosis

A 32 year old woman comes to your clinic with neck masses for the last several weeks. Masses are discrete, non matted, firm and rubbery on

co-sponsored by the Health & Physical Education Department, the Health Services Office, and the Student Development Center

CHAPTER 2. Neoplasms (C00-D49) March MVP Health Care, Inc.

Small Cell Lung Cancer

بسم هللا الرحمن الرحيم

Emory Eye Center New Patient Questionnaire

CT scans and IV contrast (radiographic iodinated contrast) utilization in adults

LEMTRADA REMS Education Program for Prescribers

Advances In Chemotherapy For Hormone Refractory Prostate Cancer. TAX 327 study results & SWOG study results presented at ASCO 2004

Mesothelioma , The Patient Education Institute, Inc. ocft0101 Last reviewed: 03/21/2013 1

PATIENT HISTORY FORM

Advanced Practice Provider Academy

What You Should Know About Cerebral Aneurysms

Ovarian Cancer. in Georgia, Georgia Department of Human Resources Division of Public Health

CHILDHOOD CANCER SURVIVOR STUDY Analysis Concept Proposal

Guide to Understanding Breast Cancer

What is Mesothelioma?

Directly Coded Summary Stage Is Back

Blood, Lymphatic and Immune Systems

Medication Guide TASIGNA (ta-sig-na) (nilotinib) Capsules

Acute myeloid leukemia (AML)

Paraneoplastic Antibodies in Clinical Practice. Mohammed El lahawi New Cross Hospital Wolverhampton

Southwest General Surgical Associates General & Vascular Surgery 8230 Walnut Hill Lane Suite 408 Dallas, TX Phone-214) Fax-214)

General Thoracic Surgery ICD9 to ICD10 Crosswalks. C34.11 Malignant neoplasm of upper lobe, right bronchus or lung

6/3/2011. High Prevalence and Incidence. Low back pain is 5 th most common reason for all physician office visits in the U.S.

The Diagnosis of Brain Tumours in Children

Transcription:

Childhood Cancer in the Primary Care Setting Mohamed Radhi, M.D. Associate Professor, UMKC Pediatric Hematology/Oncology/BMT Children s Mercy Hospital

I will discuss: Overview of childhood cancer Presentation signs and symptoms Epidemiology Diagnostic challenges Delay in diagnosis Final remarks

Overview of Childhood Cancer

Overview Childhood cancer is rare among childhood diseases. However, it is the second leading cause of death following accidents Childhood cancer is a challenging disease entity due to its rarity in nature, and it often presents with symptoms that overlap with more common, benign diseases such as ITP or rheumatologic disorders Childhood cancer can present at any age or in any organ. Although childhood cancer is usually a random event, it can be predisposed by certain genetic, familial, or immunologic disorders. Childhood cancer, can be a true life-threatening medical emergency that requires immediate and swift action to prevent loss of life.

Among the 12 major types, Leukemias and brain tumors account for more than half of all cases. The median age at diagnosis is six years old. Some forms of pediatric cancer have a 5 year survival rate of more than 90%, while others have a 5 year survival rate of less than 2%. In 80% of cases, a child s cancer diagnosis is delayed until the disease is very advanced and has spread to other parts of the body. As a stark comparison, this only occurs in 20% of adult cancer cases. Childhood cancers tend to be more aggressive than adult cancers, so this late diagnosis may significantly affect the 5- year survival probability of the child.

Presentation Table 1 Common childhood malignancies and associated clinical red flags that should prompt workup by a pediatric oncologist 7,8 Malignancy History/Symptom Sign Acute leukemia (ALL, AML) Fever Pallor Bone pain or limp Infection (particularly of an unusual location, severity, or organism) Anorexia, weight loss Fatigue Bruising Petechiae Mucosal bleeding Dyspnea Orthopnea Headache Double vision Fever Anemia WBC abnormalities (e.g. leukocytosis, peripheral blasts, leukopenia, neutropenia) Lymphadenopathy, generalized Hepatosplenomegaly Thrombocytopenia DIC Gingival hypertrophy Mediastinal mass Pleural effusion Cranial nerve palsy Lymphoma (NHL, HL) CNS tumors Lymph node swelling Fever Weight loss Night sweats Pruritis Bruising Petechiae Cough Dyspnea Orthopnea Pain Headache Vomiting Vision changes Irritability Weakness Loss of coordination Loss of developmental milestones Declining school performance Lymphadenopathy (nodes enlarged, firm, fixed, nontender) Fever Cytopenias (if bone marrow involvement) Hepatosplenomegaly Mediastinal mass Abdominal mass Intussusception Cranial nerve palsy Neurologic deficits (i.e. weakness, sensory loss) Ataxia Papilledema Parinaud s (i.e. paralysis of upward gaze) Full anterior fontanelle Abnormally increasing head circumference Seizures Neuroblastoma Wilms tumor Bone sarcoma (osteosarcoma, Ewing sarcoma) Soft tissue sarcoma (rhabdomyosarcoma and other rare sarcomas) Radhi et al Prim Care Clin Office Pract 42 (2015) 43 55 Enlarging abdomen Anorexia Weight loss Pallor Bruising Petechiae Bone pain Fever Irritability Diarrhea or constipation Back pain Enlarging abdomen Hematuria Constipation Abdominal pain Bone pain Deformity Swelling Anorexia, weight loss Symptoms due to mass effect (e.g. constipation from pelvic tumor) Palpable mass Deformity Swelling Pain Symptoms due to mass effect Abdominal mass Posterior chest mass Cytopenias Periorbital bruising ( raccoon eyes ) Proptosis Opsoclonus myoclonus ataxia syndrome Horner syndrome Bony masses Hypertension Weakness or paralysis Abdominal mass Hematuria, gross or microscopic Hypertension Palpable mass Deformity Swelling Pathologic fracture Pulmonary nodules Palpable mass Deformity Various, depending on location of tumor

Epidemiology

Epidemiology Every day in America, 43 children are diagnosed with cancer. Each year in the U.S. approx. 12-13 K children between the ages of birth and 19 years of age are diagnosed with cancer. This translates to about 1 in 7000 children diagnosed with cancer, and childhood cancer accounts for about 1% of all cancer diagnoses in the United States. There is no known cause of childhood cancer, and it occurs regularly and randomly across all ethnic groups. Some children are even born with cancer The 5-year survival rates for all childhood cancers combined increased from 58.1% from 1975 to 1977 to 79.6% from 1996 to 2003. Although the survival rate for childhood cancers has increased from less than 50% in 1970 to almost 80% today, cancers remain the leading cause of childhood death from disease.

Epidemiology In the 12400 new diagnoses/year < 20 yo 0-14 = 8,700 15-19 = 3,700 The probability of a newborn developing cancer by age 20 is between 0.3 0.32%, or ~ 1/300 1,500-1,600 deaths/year in children < 15 years of age

Age Specific Incidence Rates for Childhood Cancers

Most Common Childhood Cancers

Age-Adjusted and Age Specific Cancer Incidence SEER 2005-2009

Age Specific Incidence Rates for Childhood Cancers Most common cancer < 15 yrs leukemia > 15 yrs lymphoma Second most common < 10 yrs CNS tumors 10-14 yrs lymphoma > 15 yrs leukemia

SEER Delay-Adjusted Incidence and Mortality For ALL Childhood Cancers, 1975-2011

Trend in Survival Rates for Specific Childhood Cancers

Diagnostic Challenges

Diagnostic Challenges Childhood cancer can be difficult to diagnose in the primary care setting. For a pediatric oncologist, the index of suspicion of cancer is very high. The opposite for the general physician with Only about 1-2 percent of all cancers in western industrialized nations occur in children The presenting signs and symptoms are often nonspecific and mimic those of common childhood conditions such as viral infections or rheumatological disorders. There may also be a general reluctance to consider such a diagnosis as cancer carries with it the fear of death, is rare in childhood, and is an unfamiliar diagnosis for the non-specialist

Diagnosis Delay of Childhood Cancer Because pediatric cancers often present with vague symptoms, it is not surprising that there is often a delay in diagnosis. Appropriate early diagnosis and treatment require primary care physicians and parents to be aware of early symptoms of childhood malignancies. Tumors in children are very invasive but are more responsive to treatment than adult tumors. Misinterpretation of ambiguous cancer symptoms by patients, parents, and physicians may lead to diagnosis delay

Diagnosis Delays in Childhood Cancer Tam Dang-Tan, MSc, Eduardo L. Franco, DrPH

Diagnosis Delays in Childhood Cancer Tam Dang-Tan, MSc, Eduardo L. Franco, DrPH CANCER August 15, 2007 / Volume 110 / Number 4

Final Remarks Making the diagnosis of a childhood malignancy is often very difficult in the early stages of disease. Many of the presenting symptoms are common and typically not caused by cancer. Early diagnosis of childhood cancer is critical, as survival rates have increased dramatically over the past decades. Prolonged delay in diagnosis is common, especially for brain tumors and certain lymphomas (Hodgkin disease). When one encounters symptoms suspicious for a childhood malignancy, it is imperative that the child be referred to a pediatric cancer center.

https://www.youtube.com/watch?v =YH8NZAW0wNg

Thank You!